Software - Application
Compare Stocks
5 / 10Stock Comparison
RSSS vs INFU vs BRT vs CODA vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
REIT - Residential
Aerospace & Defense
REIT - Healthcare Facilities
RSSS vs INFU vs BRT vs CODA vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Medical - Instruments & Supplies | REIT - Residential | Aerospace & Defense | REIT - Healthcare Facilities |
| Market Cap | $86M | $170M | $276M | $136M | $3.65B |
| Revenue (TTM) | $49M | $142M | $98M | $28M | $403M |
| Net Income (TTM) | $4M | $8M | $-12M | $4M | $148M |
| Gross Margin | 50.2% | 56.7% | 40.7% | 66.3% | 61.3% |
| Operating Margin | 6.9% | 9.1% | 6.1% | 17.4% | 48.5% |
| Forward P/E | 65.0x | 19.8x | — | 22.8x | 21.0x |
| Total Debt | $0.00 | $3M | $508M | $395K | $1.16B |
| Cash & Equiv. | $12M | $3M | $25M | $29M | $20M |
RSSS vs INFU vs BRT vs CODA vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Research Solutions,… (RSSS) | 100 | 85.8 | -14.2% |
| InfuSystem Holdings… (INFU) | 100 | 72.4 | -27.6% |
| BRT Apartments Corp. (BRT) | 100 | 130.0 | +30.0% |
| Coda Octopus Group,… (CODA) | 100 | 216.3 | +116.3% |
| National Health Inv… (NHI) | 100 | 135.6 | +35.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RSSS vs INFU vs BRT vs CODA vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RSSS has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 9.9%, EPS growth 130.8%, 3Y rev CAGR 14.2%
- Beta 0.57 vs INFU's 1.38
- 8.6% ROA vs BRT's -1.7%, ROIC 51.4% vs 1.3%
INFU ranks third and is worth considering specifically for value.
- Lower P/E (19.8x vs 21.0x)
BRT is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 0.60, yield 7.2%
- Beta 0.60, yield 7.2%, current ratio 0.86x
- 7.2% yield, vs NHI's 4.8%, (3 stocks pay no dividend)
CODA is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 8.6% 10Y total return vs BRT's 217.1%
- Lower volatility, beta 0.99, Low D/E 0.7%, current ratio 8.86x
- 30.7% revenue growth vs BRT's 1.5%
- +78.9% vs RSSS's -7.5%
NHI is the clearest fit if your priority is quality.
- 36.8% margin vs BRT's -12.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.7% revenue growth vs BRT's 1.5% | |
| Value | Lower P/E (19.8x vs 21.0x) | |
| Quality / Margins | 36.8% margin vs BRT's -12.5% | |
| Stability / Safety | Beta 0.57 vs INFU's 1.38 | |
| Dividends | 7.2% yield, vs NHI's 4.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +78.9% vs RSSS's -7.5% | |
| Efficiency (ROA) | 8.6% ROA vs BRT's -1.7%, ROIC 51.4% vs 1.3% |
RSSS vs INFU vs BRT vs CODA vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RSSS vs INFU vs BRT vs CODA vs NHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 1 of 6 categories
INFU leads 1 • RSSS leads 1 • CODA leads 1 • BRT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI is the larger business by revenue, generating $403M annually — 14.4x CODA's $28M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to BRT's -12.5%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $142M | $98M | $28M | $403M |
| EBITDAEarnings before interest/tax | $5M | $26M | $33M | $6M | $282M |
| Net IncomeAfter-tax profit | $4M | $8M | -$12M | $4M | $148M |
| Free Cash FlowCash after capex | $8M | $20M | $13M | $7M | $226M |
| Gross MarginGross profit ÷ Revenue | +50.2% | +56.7% | +40.7% | +66.3% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +6.9% | +9.1% | +6.1% | +17.4% | +48.5% |
| Net MarginNet income ÷ Revenue | +7.9% | +5.6% | -12.5% | +14.8% | +36.8% |
| FCF MarginFCF ÷ Revenue | +15.5% | +14.3% | +13.0% | +24.6% | +56.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.0% | -3.0% | +4.2% | +28.8% | +29.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +126.6% | +5.9% | -16.7% | +3.0% | +10.8% |
Valuation Metrics
INFU leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, NHI trades at a 62% valuation discount to RSSS's 65.0x P/E. On an enterprise value basis, INFU's 6.7x EV/EBITDA is more attractive than BRT's 20.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $86M | $170M | $276M | $136M | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $73M | $170M | $759M | $108M | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | 65.00x | 27.13x | -22.21x | 32.73x | 24.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 19.79x | — | 22.85x | 20.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 7.64x | — |
| EV / EBITDAEnterprise value multiple | 19.57x | 6.75x | 20.29x | 18.25x | 17.20x |
| Price / SalesMarket cap ÷ Revenue | 1.74x | 1.18x | 2.84x | 5.14x | 9.64x |
| Price / BookPrice ÷ Book value/share | 5.73x | 3.10x | 1.49x | 2.34x | 2.30x |
| Price / FCFMarket cap ÷ FCF | 12.22x | 7.12x | 41.53x | 22.60x | 16.56x |
Profitability & Efficiency
RSSS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
RSSS delivers a 26.7% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-7 for BRT. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRT's 2.87x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs BRT's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +26.7% | +14.0% | -6.8% | +7.2% | +9.8% |
| ROA (TTM)Return on assets | +8.6% | +7.9% | -1.7% | +6.6% | +5.4% |
| ROICReturn on invested capital | +51.4% | +12.5% | +1.3% | +11.2% | +5.6% |
| ROCEReturn on capital employed | +11.2% | +14.3% | +1.6% | +8.1% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 3 | 7 | 6 |
| Debt / EquityFinancial leverage | — | 0.06x | 2.87x | 0.01x | 0.76x |
| Net DebtTotal debt minus cash | -$12M | $241,000 | $483M | -$28M | $1.1B |
| Cash & Equiv.Liquid assets | $12M | $3M | $25M | $29M | $20M |
| Total DebtShort + long-term debt | $0 | $3M | $508M | $394,932 | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 15.54x | 0.51x | — | 3.45x |
Total Returns (Dividends Reinvested)
CODA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CODA five years ago would be worth $15,586 today (with dividends reinvested), compared to $4,466 for INFU. Over the past 12 months, CODA leads with a +78.9% total return vs RSSS's -7.5%. The 3-year compound annual growth rate (CAGR) favors NHI at 20.2% vs INFU's -1.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -11.3% | +0.2% | +3.1% | +27.3% | -0.9% |
| 1-Year ReturnPast 12 months | -7.5% | +53.7% | +1.8% | +78.9% | +4.0% |
| 3-Year ReturnCumulative with dividends | +26.5% | -3.6% | +0.6% | +36.8% | +73.9% |
| 5-Year ReturnCumulative with dividends | +16.6% | -55.3% | +10.9% | +55.9% | +32.5% |
| 10-Year ReturnCumulative with dividends | +160.0% | +143.1% | +217.1% | +861.1% | +59.2% |
| CAGR (3Y)Annualised 3-year return | +8.2% | -1.2% | +0.2% | +11.0% | +20.2% |
Risk & Volatility
Evenly matched — BRT and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.09 beta — it tends to amplify market swings less than INFU's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BRT currently trades 87.8% from its 52-week high vs RSSS's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.57x | 1.38x | 0.60x | 0.99x | -0.09x |
| 52-Week HighHighest price in past year | $4.12 | $11.04 | $16.69 | $17.28 | $90.94 |
| 52-Week LowLowest price in past year | $2.15 | $5.08 | $13.18 | $5.98 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +63.1% | +76.2% | +87.8% | +70.1% | +82.8% |
| RSI (14)Momentum oscillator 0–100 | 56.3 | 37.4 | 62.1 | 48.3 | 33.9 |
| Avg Volume (50D)Average daily shares traded | 46K | 125K | 54K | 255K | 329K |
Analyst Outlook
Evenly matched — RSSS and BRT and NHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: INFU as "Buy", BRT as "Buy", CODA as "Buy", NHI as "Hold". Consensus price targets imply 78.4% upside for INFU (target: $15) vs 13.5% for NHI (target: $85). For income investors, BRT offers the higher dividend yield at 7.16% vs NHI's 4.79%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $15.00 | $21.00 | $14.00 | $85.40 |
| # AnalystsCovering analysts | — | 3 | 5 | 1 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | — | +7.2% | — | +4.8% |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — | $1.05 | — | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +6.5% | +1.8% | 0.0% | 0.0% |
NHI leads in 1 of 6 categories (Income & Cash Flow). INFU leads in 1 (Valuation Metrics). 2 tied.
RSSS vs INFU vs BRT vs CODA vs NHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RSSS or INFU or BRT or CODA or NHI a better buy right now?
For growth investors, Coda Octopus Group, Inc.
(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus 1. 5% for BRT Apartments Corp. (BRT). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate InfuSystem Holdings, Inc. (INFU) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RSSS or INFU or BRT or CODA or NHI?
On trailing P/E, National Health Investors, Inc.
(NHI) is the cheapest at 24. 9x versus Research Solutions, Inc. at 65. 0x. On forward P/E, InfuSystem Holdings, Inc. is actually cheaper at 19. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RSSS or INFU or BRT or CODA or NHI?
Over the past 5 years, Coda Octopus Group, Inc.
(CODA) delivered a total return of +55. 9%, compared to -55. 3% for InfuSystem Holdings, Inc. (INFU). Over 10 years, the gap is even starker: CODA returned +861. 1% versus NHI's +59. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RSSS or INFU or BRT or CODA or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 09β versus InfuSystem Holdings, Inc. 's 1. 38β — meaning INFU is approximately -1649% more volatile than NHI relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 3% for BRT Apartments Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — RSSS or INFU or BRT or CODA or NHI?
By revenue growth (latest reported year), Coda Octopus Group, Inc.
(CODA) is pulling ahead at 30. 7% versus 1. 5% for BRT Apartments Corp. (BRT). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -26. 9% for BRT Apartments Corp.. Over a 3-year CAGR, RSSS leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RSSS or INFU or BRT or CODA or NHI?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus -12. 3% for BRT Apartments Corp. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 5. 1% for RSSS. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RSSS or INFU or BRT or CODA or NHI more undervalued right now?
On forward earnings alone, InfuSystem Holdings, Inc.
(INFU) trades at 19. 8x forward P/E versus 22. 8x for Coda Octopus Group, Inc. — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INFU: 78. 4% to $15. 00.
08Which pays a better dividend — RSSS or INFU or BRT or CODA or NHI?
In this comparison, BRT (7.
2% yield), NHI (4. 8% yield) pay a dividend. RSSS, INFU, CODA do not pay a meaningful dividend and should not be held primarily for income.
09Is RSSS or INFU or BRT or CODA or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 09), 4. 8% yield). Both have compounded well over 10 years (NHI: +59. 2%, INFU: +143. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RSSS and INFU and BRT and CODA and NHI?
These companies operate in different sectors (RSSS (Technology) and INFU (Healthcare) and BRT (Real Estate) and CODA (Industrials) and NHI (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RSSS is a small-cap quality compounder stock; INFU is a small-cap quality compounder stock; BRT is a small-cap income-oriented stock; CODA is a small-cap high-growth stock; NHI is a small-cap income-oriented stock. BRT, NHI pay a dividend while RSSS, INFU, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.